Why the study?
Heart failure remains a leading cause of global morbidity and mortality, with a growing burden driven by aging and cardiovascular risk factors alongside recent developments in innovative management strategies.
Design
Review
Key result
Modern multidisciplinary approaches, including pharmacological and device-based therapies, contribute to improved survival, reduced hospitalization rates, and enhanced quality of life in heart failure.
Authors
Loading...
No specific finding reported; leaves open which contemporary HF strategies merit adoption.
Modern multidisciplinary approaches, including novel pharmacological and device therapies, improve survival and quality of life in heart failure patients.
Husniddin Umurqulov (2026) conducted a review in Heart failure. Modern multidisciplinary approaches was evaluated. Modern multidisciplinary approaches, including pharmacological and device-based therapies, contribute to improved survival, reduced hospitalization rates, and enhanced quality of life in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: